Casopitant
(Redirected from Rezonic)
Casopitant is a potent and selective neurokinin 1 (NK1) receptor antagonist that plays a significant role in the management of chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV). It operates by blocking the action of substance P in the central nervous system (CNS), which is a key neurotransmitter involved in inducing vomiting.
Mechanism of Action[edit | edit source]
Casopitant works by inhibiting the NK1 receptors, which are predominantly located in the brain's vomiting center. Substance P, a neuropeptide, binds to these receptors and is implicated in the vomiting reflex. By preventing substance P from binding to NK1 receptors, casopitant effectively reduces the incidence and severity of nausea and vomiting associated with chemotherapy and surgery.
Clinical Uses[edit | edit source]
Casopitant is used as part of antiemetic therapy in patients undergoing chemotherapy and surgical procedures. It is often combined with other antiemetic agents, such as 5-HT3 receptor antagonists and dexamethasone, to enhance efficacy in preventing CINV and PONV.
Chemotherapy-Induced Nausea and Vomiting[edit | edit source]
In the context of chemotherapy, casopitant is used to prevent both acute and delayed phases of nausea and vomiting. Its effectiveness has been demonstrated in various clinical trials, making it a valuable component of antiemetic regimens for patients receiving highly emetogenic chemotherapy agents.
Postoperative Nausea and Vomiting[edit | edit source]
Casopitant is also used to prevent nausea and vomiting after surgery. Its ability to reduce the incidence of PONV makes it a useful option for patients who are at high risk of experiencing these symptoms postoperatively.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of casopitant includes oral and intravenous formulations, allowing for flexibility in administration. It is well absorbed when taken orally, with peak plasma concentrations occurring within a few hours. Casopitant is metabolized primarily in the liver and eliminated through both renal and fecal pathways.
Adverse Effects[edit | edit source]
While casopitant is generally well tolerated, some patients may experience side effects such as headache, constipation, and fatigue. Rarely, more serious adverse effects, including liver enzyme elevations and hypersensitivity reactions, have been reported.
Regulatory Status[edit | edit source]
As of the last update, casopitant has undergone extensive clinical trials to evaluate its safety and efficacy. However, the regulatory approval status may vary by country, and it is essential to consult local medical guidelines and regulatory agencies for the most current information.
Conclusion[edit | edit source]
Casopitant represents a significant advancement in the management of nausea and vomiting associated with chemotherapy and surgery. Its role as an NK1 receptor antagonist offers a targeted approach to preventing these distressing symptoms, improving the quality of life for patients undergoing treatment.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD